ABC.L Regulatory News (ABC)

24 Sep 2008 10:19



ABCAM PLC

("Abcam" or "the Company")

Directors' Dealings

Cambridge UK, 24 September 2008: Abcam plc announces that to meet demand from institutional investors the following transactions have been undertaken by Directors:

* 7,500 of these shares were sold by his wife Jane Dominey

For further information please contact:

Notes for editors:

About Abcam plc

Abcam is a producer and distributor of research-grade antibodies headquartered in Cambridge, UK, with a US office located in Cambridge, Massachusetts and a Japanese office in Tokyo. Abcam was admitted to AIM in November 2005 and trades under the ticker symbol ABC. The Company produces and distributes its own and third party produced antibodies to academic and commercial users throughout the world with product information provided and ordering available through the Company's website, www.abcam.com. The antibodies are sold under the Abcam brand name. The Company's vision is to build the largest online antibody resource in the world while also ensuring that the antibodies are of high quality and commercially viable. Abcam now has an online catalogue of over 45,000 products, most of which are antibodies, from over 200 suppliers supported by up-to-date and detailed technical data sheets, which are created by the Company. The Company currently employs 180 staff in its three operating companies.